Protease Inhibitors and Carcinogenesis: A Review

References

• Troll W, Frenkel K, Wiesner R. Protease inhibitors as anticarcinogens. J Natl Cancer Inst 1984; 73: 1245–1250
   PubMed Web of Science ®Google Scholar
• Kennedy A. Prevention of carcinogenesis by protease inhibitors. Cancer Res 1994; 54: 1999s–2005s
   PubMed Web of Science ®Google Scholar
• Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 1992; 18: 1–29
   PubMed Web of Science ®Google Scholar
• Goldbohm R, Van den Brandt P, van'tVeer P, et al. A prospective cohort study on the relation between meat consumption and the risk of colon cancer. Cancer Res 1994; 54: 718–723
   PubMed Web of Science ®Google Scholar
• Willett W, Stampfer M, Colditz G, Rosner B, Heimekens C, Speizer F. Dietary fat and the risk of breast cancer. N Engl J Med 1987; 316: 22–28
   PubMed Web of Science ®Google Scholar
• Enstrom J. Reassessment of the role of dietary fat in cancer etiology. Cancer Res 1981; 41: 3722–3723
   PubMed Web of Science ®Google Scholar
• Hirayama T. Relationship of soybean paste soup intake to gastric cancer risk. Nutr Cancer 1982; 3: 223–233
   PubMedGoogle Scholar
• Birk Y. The Bowman-Birk inhibitor: Trypsin- and chymotrypsin-inhibitor from soybeans. Int J Peptide Prot Res 1985; 25: 113–131
   PubMedGoogle Scholar
• Eldridge A, Kwolek W. Soybean isoflavones: Effect of environment and variety on composition. J Agr Food Chem 1983; 31: 394–396
   PubMed Web of Science ®Google Scholar
• Messina M, Barnes S. Commentary. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 1991; 83: 541–546
   PubMed Web of Science ®Google Scholar
• Calam J, Bojarski J, Springer C. Raw soya-bean flour increases cholecystokinm release in man. Br J Nutr 1987; 58: 175–179
   PubMed Web of Science ®Google Scholar
• Troll W, Weisner R, Frenkel K. Anticarcinogenic action of protease inhibitors. Adv Cancer Res 1987; 49: 265–283
   PubMed Web of Science ®Google Scholar
• Barnes S, Grubbs C, Setchell K, Carlson, 3. Soybeans inhibit mammary tumors in models of breast cancer. Mutagens and Carcinogens in the Diet, M Pariza. Wiley-Liss, New York 1990; 239–253
   Google Scholar
• Yavelow J, Finlay T, Kennedy A, Troll W. Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res 1983; 43: 2454s–2459s
   PubMed Web of Science ®Google Scholar
• Madar Z, Gertler A, Birk Y. The fate of the Bowman Birk trypsin inhibitor from soybeans in the digestive tract. Comp Biochem Physiol 1979; 62A: 1057–1061
   Google Scholar
• Axelson M, Sjovall J, Gustafsson B, et al. Soya—A dietary source of the non-steroidal oestrogen equol in man and animals. J Endo-crinol 1984; 102: 49–56
   PubMed Web of Science ®Google Scholar
• Barbuch R, Coutant J, Welsh M, et al. The use of thermospray liquid chromatography/tandem mass spectrometry for the class identification and structural verification of phytoestrogens in soy protein preparations. Bioraed Environ Mass Spectrom 1989; 18: 973–977
   PubMedGoogle Scholar
• Martin P, Horowitz K, Ryan D, McGuire W. Phytoestrogen interaction with estrogen receptors inhuman breast cells. Endocrinology 1978; 103: 1860–1867
   PubMed Web of Science ®Google Scholar
• Mathieson R, Kitts W. Binding of phytoestrogens and estradiol 17b by cytoplasmic receptors in the pituitary gland and the hypothalamus of the ewe. J Endocrinol 1980; 85: 317–325
   PubMed Web of Science ®Google Scholar
• Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262: 5592–5595
   PubMed Web of Science ®Google Scholar
• Weihrauch J, Gardner J. Slerol content of foods of plant origin. J Am Diet Assoc 1978; 73: 39–47
   PubMed Web of Science ®Google Scholar
• Oakenfull D. Saponins in food—A review. Food Chem 1981; 6: 19–40
   Web of Science ®Google Scholar
• Raicht R, Cohen B, Fazzini E, et al. Protective effect of plant slerols against chemically induced colon tumors in rats. Cancer Res 1980; 40: 403–405
   PubMed Web of Science ®Google Scholar
• Deschner E, Cohen B, Raicht R. The kinetics of the protective effect of b-sitosterol against MNU-induced colonic ncoplasia. J Cancer Res Clin Oncol 1982; 103: 49–54
   PubMed Web of Science ®Google Scholar
• Graf E, Eaton J. Dietary suppression of colonic cancer: Fiber or phytate?. Cancer 1985; 56: 717–718
   PubMed Web of Science ®Google Scholar
• Shamsuddin A, Ullah A, Chakravarthy A. Inositol and inositol hexaphosphate suppresses cell proliferation and tumor formation in CD-1 mice. Carcinogenesis 1989; 10: 1461–1463
   PubMed Web of Science ®Google Scholar
• Graf E, Eaton J. Antioxidant functions of phytic acid. Free Radic Biol Med 1990; 8: 61–69
   PubMed Web of Science ®Google Scholar
• Graf J, Mahoney J, Bryant R, et al. Iron-catalyzed hydroxyl formation. J Biol Chem 1984; 259: 3620–3624
   PubMed Web of Science ®Google Scholar
• Birt D, Bresnick E. Chemoprevention by nonnutrient components of vegetables and fruits. Human Nutrition: A Comprehensive Treatise. Plenum Press, New York 1990
   Google Scholar
• Wei H, Tye L, Bresnick E, Birt D. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 1990; 50: 499–502
   PubMed Web of Science ®Google Scholar
• Osawa T, Kumon H, Namiki M, Kawakishi S, Fukuda Y. Antimutagenic heat stable antioxidants. Mutagens and Carcinogens in the Diet, M Pariza, J Felton, H Aeschbacher, S. Sato. Wiley-Liss, New York 1990; 223–238
   Google Scholar
• Crowell P, Gould M. Chemoprevention and therapy of cancer by D-limonene. Crit Rev Oncogenesis 1994; 5: 1–22
   PubMed Web of Science ®Google Scholar
• Crowell P, Ren Z, Lin S, Vedejs E, Gould M. Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem Pharm 1994; 47: 1405–1415
   PubMed Web of Science ®Google Scholar
• Raiten D, Titus E. Evaluation of Evidence for the Carcinogenicity of Butylated Hydroxyamsole (BHA). Life Sciences Research Office, FASEB, Bethesda, MD 1994
   Google Scholar
• Boutwell R. Opportunities for nutritional scientists in cancer prevention. Mutagens and Carcinogens in the Diet, M Pariza, J Felton, H Aeschbacher, S Sato. Wiley-Liss, New York 1990; 269–284
   Google Scholar
• Ip C, Carter C, Ip M. Requirement of essential fatty acid for mammary tumorigenesis. Cancer Res 1985; 45, 1997–2001
   Web of Science ®Google Scholar
• Pariza M, Ha Y. Conjugated dienoic derivatives of linoleic acid: Mechanism of anticarcinogenic effect. Mutagens and Carcinogens in the Diet, M Pariza, J Felton, H Aeschbacher, S Sato. Wiley-Liss, New York 1990; 217–222
   Google Scholar
• Billings P, Brandon D, Habres J. Internalization of the Bowman-Birk protease inhibitor by intestinal epithelial cells. Eur J Cancer 1991; 27: 903–908
   PubMed Web of Science ®Google Scholar
• Yavelow J, Scott C, Mayer T. Fluorescent visualization of binding and internalization of the anticarcinogenic Bowman-Birk type protease inhibitors in transformed fibroblasts. Cancer Res 1987; 47: 1602–1607
   PubMed Web of Science ®Google Scholar
• Schelp F, Pongpaew P. Protection against cancer through nutritionally-induced increase of endogenous proteinase inhibitors—An hypothesis. Int J Epidemiol 1988; 17: 287–292
   PubMed Web of Science ®Google Scholar
• Billings P, St. Clair W, Ryan C, Kennedy A. Inhibition of radiation-induced transformation of C3H/10T1/2 cells by chymotrypsin inhibitor 1 from potatoes. Carcinogenesis 1987; 8: 809–812
   PubMed Web of Science ®Google Scholar
• Gertler A, Poraz I, Cohen N, Gottesfeld F. Inhibition of human and dog serine pancreatic proteinases by naturally occurring high-molecular-weight inhibitors from plant or animal origin. Biochem Med 1982; 27: 143–153
   PubMedGoogle Scholar
• Gurusiddaiah S, Kuo T, Ryan C. Immunological comparisons of chymotrypsin inhibitor I among several genera of the Solanaceae. Plant Phys 1972; 50: 627–631
   PubMed Web of Science ®Google Scholar
• Plunkett G, Senear D, Zuroske G, Ryan C. Proteinase inhibitors I and II from leaves of wounded tomato plants: Purification and properties. Arch Biochem Biophys 1982; 213: 463–472
   PubMed Web of Science ®Google Scholar
• Kuo T, Pearce G, Ryan C. Isolation and characterization of proteinase inhibitor 1 from etiolated tobacco leaves. Arch Biochem Biophys 1984; 230: 504–510
   PubMed Web of Science ®Google Scholar
• Liener I, Goodale R, Deshmukh A, et al. Effect of a trypsin inhibitor from soybeans (Bowman-Birk) on the secretory activity of the human pancreas. 1988
   Google Scholar
• Liddle R, Goldfine I, Williams J. Bioassay of plasma cholecystokinin in rats: Effects of food, trypsin inhibitor, and alcohol. Gastroenterology 1984; 87: 542–549
   PubMed Web of Science ®Google Scholar
• Nitsan Z, Liener I. Enzyniic activities in the pancreas, digestive tract, and feces of rats fed raw or heated soy flour. J Nutr 1976; 106: 300–305
   PubMed Web of Science ®Google Scholar
• Howatson A. The potential of cholecystokinin as a cocarcinogen in the hamster-nitrosamine model. Nutritional and Toxicological Significance of Enzyme Inhibitors inFoods, M Friedman. Plenum Press, New York 1986; 109–121
   Google Scholar
• Roebuck B. Enhancement of pancreatic carcinogenesis by raw soy protein isolate. Quantitative rat model and nutritional considerations. Nutritional and Toxicological Significance of Enzyme Inhibitors in Foods, M Friedman. Plenum Press, New York 1986; 91–108
   Google Scholar
• Troll W, Klassen A, Janoff A. Tumorigenesis in mouse skin: Inhibition by synthetic inhibitors of proteases. Science 1970; 169: 1211–1213
   PubMed Web of Science ®Google Scholar
• Schiessler H, Ohlsson K, Olsson I, Amhold M, Birk Y, Fritz H. Elastases from human and canine granulocytes. II. Interaction with protease inhibitors of animal, plant, and microbial origin. Hoppe-Seyler Z Physiol Chem 1977; 358: 53–58
   PubMedGoogle Scholar
• Hojima Y, Pisano J, Cochrane C. Survey of plant inhibitors of polymorphonuclear leukocyte elastase, pancreatic elastase, cathepsin G, cathepsin B, hageman factor fragments, and other serine proteinases. Biochem Pharm 1983; 32: 985–990
   PubMed Web of Science ®Google Scholar
• Hozumi M, Ogawa M, Sugimura T, Takeuchi T, Umezawa H. Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from Actinomyceles. Cancer Res 1972; 32: 1725–1728
   PubMed Web of Science ®Google Scholar
• Fischer S, Mills G, Slaga T. Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism. Carcinogenesis 1982; 3: 1243–1245
   PubMed Web of Science ®Google Scholar
• Verma A, Garcia C, Ashendel C, Boutwell R. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. Cancer Res 1983; 43: 3045–3049
   PubMed Web of Science ®Google Scholar
• Aldaz C, Conti C, Gimenez I, Slaga T, Klein-Szanto A. Cutaneous changes during prolonged application of 12–0-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment. Cancer Res 1985; 45: 2753–2759
   PubMed Web of Science ®Google Scholar
• Troll W. Prevention of cancer by agents that suppress oxygen radical formation. Free Rad Res Commun 1991; 751–757, 12–13
   PubMedGoogle Scholar
• Goldstein B, Witz G, Amoruso M, Troll W. Protease inhibitors antagonize the activation of polymorphonuclear leukocyte oxygen consumption. Biochem Biophys Res Commun 1979; 88: 854–860
   PubMed Web of Science ®Google Scholar
• Zacharski L, Meehan K, Algarra S, Calvo F. Clinical trials with anticoagulant and antiplatelet therapies. Cancer Metast Rev 1992; 11: 421–431
   PubMed Web of Science ®Google Scholar
• Burger M. Proteolytic enzymes initiating cell division and escape from contact inhibition of growth. Nature 1970; 227: 170–171
   PubMed Web of Science ®Google Scholar
• Cuimingham D, Ho T. Effects of added proteases on concanavalin A-specific agglutinability and proliferation of quiescent fibroblasts. Proteases and Biological Control, E Reich, D Rifkin, E Shaw. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 1975; 795–806
   Google Scholar
• Schnebli H, Burger M. Selective inhibition of growth of transformed cells by protease inhibitors. Proc Natl Acad Sci USA 1972; 69: 3825–3827
   PubMed Web of Science ®Google Scholar
• Clawson G, Ren L, Isom H. Nuclear scaffold protease: In situ nuclear localization and effects of a protease inhibitor on growth and morphology of ras-transformed hepatocytes. Hepatology 1995; 22: 1230–1235
   PubMed Web of Science ®Google Scholar
• Kuroki T, Drevon C. Inhibition of chemical transformation in C3H/10T1/2 cells by protease inhibitors. Cancer Res 1979; 39: 2755–2761
   PubMed Web of Science ®Google Scholar
• Kennedy A, Little J. Protease inhibitors suppress radiation induced malignant transformation in vitro. Nature 1978; 276: 825–826
   PubMed Web of Science ®Google Scholar
• Kennedy A, Little J. Effects of protease inhibitors on radiation transformation in vitro. Cancer Res 1981; 41: 2103–2108
   PubMed Web of Science ®Google Scholar
• Garte S, Currie D, Troll W. Inhibition of H-ras oncogene transformation of NIH3T3 cells by protease inhibitors. Cancer Res 1989; 47: 3159–3162
   Web of Science ®Google Scholar
• Clawson G, Norbeck L, Wise J, Patierno S. An inhibitor of nuclear scaffold protease blocks chemical transformation of fibroblasts. Cell Growth Diff 1993; 4: 589–594
   PubMedGoogle Scholar
• Ku G, Quigley J, Sultzer B. The inhibition of the mitogenic stimulation of B lymphocytes by a serine protease inhibitor: Commitment to proliferation correlates with an enhanced expression of a cell-associated arginine-specific serine enzyme. J Immunol 1983; 131: 2494–2499
   PubMed Web of Science ®Google Scholar
• Auberger P, Mary D, Breittmayer J, Aussel C, Fehlmann M. Chymotryptic-type protease inhibitors block the increase in Ca2+ and IL-2 production in activated jurkat T cells. J Immunol 1989; 142: 1253–1259
   PubMed Web of Science ®Google Scholar
• Sugatani J, Miwa M, Hanahan D. Platelet-activating factor stimulation of rabbit platelets is blocked by serine protease inhibitor (chymotryptic protease inhibitor). J Biol Chem 1987; 262: 5740–5747
   PubMed Web of Science ®Google Scholar
• O'Domiell-Tormey J, Quigley J. Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts. Proc Natl Acad Sci USA 1983; 80: 344–348
   PubMed Web of Science ®Google Scholar
• Jakobs K, Aktories K. Stimulation of high-affinity GTPase by trypsin and trypsin-like proteinases in membranes of human platelets. Biochem J 1988; 249: 639–643
   PubMed Web of Science ®Google Scholar
• Ponzio G, Contreres J, Debant A, Auberger P, Farahifar D, Rossi B. Inhibitors of chymotrypsin-like activities selectively block the mitotic pathway in rat hepatoma cells. Growth Factors 1990; 4: 37–44
   PubMedGoogle Scholar
• Clawson U, Noraeck L, Halem C, et al. Ca2+-regulaled serine protease associated with the nuclear scaffold. Cell Growth Diff 1992; 3: 827–838
   PubMedGoogle Scholar
• Chang J, Li J, Billings P, Kennedy A. Effects of protease inhibitors on c-myc expression in normal and transformed C3H10T1/2 cells. Mol Carcinogen 1990; 3: 226–232
   PubMed Web of Science ®Google Scholar
• Caggana M, Kennedy A. C-fos mRNA levels are reduced in the presence of antipain and the Bowman-Birk inhibitor. Carcinogenesis 1989; 10: 2145–2148
   PubMed Web of Science ®Google Scholar
• Cox L, Motz J, Troll W, Garte S. Antipain-induced suppression of oncogene expression in H-ras-transformed NIH3T3 cells. Cancer Res 1991; 51: 4810–4814
   PubMed Web of Science ®Google Scholar
• Brown R, Clark R, Chiu J, Stubblefield E. Protease activation of GI nuclei isolated from Chinese hamster fibroblasts. Exp Cell Res 1977; 104: 207–213
   PubMed Web of Science ®Google Scholar
• Wimersberger U. The selective advantage of cancer cells: A consequence of genome mobilization in the course of the induction of DNA repair processes? (Model studies on yeast). Adv Enzyme Reg 1984; 22: 311–322
   PubMedGoogle Scholar
• Fornace A. Mammalian genes induced by radiation: Activation of genes associated with growth control. Annu Rev Genet 1992; 26: 507–526
   PubMed Web of Science ®Google Scholar
• Smith M, Chen I, Zhan Q, et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 1994; 266: 1376–1380
   PubMed Web of Science ®Google Scholar
• Livingstone L, White A, Sprouse J, Livanos E, Jacks T, Tlsty T. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992; 70: 923–935
   PubMed Web of Science ®Google Scholar
• Little J, Mount D. The SOS regulatory system of Escherichia coli. Cell 1982; 29: 11–22
   PubMed Web of Science ®Google Scholar
• Kadhim M, Macdonald D, Goodhead D, Lorimore S, Marsden S, Wright E. Transmission of chromosomal instability after plutonium α-particle irradiation. Nature 1992; 355: 738–740
   PubMed Web of Science ®Google Scholar
• Gaziev A, Kutsy M. Gamma-irradiated DNA activates histone HI-specific proteinase of rat liver nuclei. Jnt J Radiat Biol 1992; 61: 169–174
   PubMed Web of Science ®Google Scholar
• Sugawara N, Ivanov K, Fishman-Lobell J, Ray B, Wu X, Haber J. DNA structure-dependent requirements for yeast RAD genes in gene conversion. Nature 1995; 373: 84–86
   PubMed Web of Science ®Google Scholar
• Billings P, St. Clair W, Owen A, Kennedy A. Potential intracellular target proteins of the anticarcinogenic Bowman-Birk protease inhibitoridentifiedby affinity chroraatography. Cancer Res 1988; 48: 1798–1802
   PubMed Web of Science ®Google Scholar
• Potempa J, Korzus E, Travis J. The serpin superfamily of proteinase inhibitors: Structure, function, and regulation. J Biol Chem 1994; 269: 15957–15960
   PubMed Web of Science ®Google Scholar
• Perlmutter D, Travis J, Punsal P. Elastase regulates the synthesis of its inhibitor, α1-proteinase inhibitor, and exaggerates the defect in homozygous pizz α1-PI deficiency. J Clin Invest 1988; 81: 1774–1780
   PubMed Web of Science ®Google Scholar
• Perlmutter D, Joslin G, Nelson P, Schasteen C, Adams S, Fallon R. Endocytosis and degradation of α1 -antitrypsin-protease complexes is mediated by the serpin-enzyme complex (SEC) receptor. J Biol Chem 1990; 265: 16713–16716
   PubMed Web of Science ®Google Scholar
• Perlmutter D, Glover G, Rivetna M, Schasteen C, Fallon R. Idenlification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes. Proc Natl Acad Sci USA 1990; 87: 3753–3757
   PubMed Web of Science ®Google Scholar
• Zou Z, Anisowicz A, Hendrix M, et al. Maspin, a serpin with tumor-suppressing activily in human mammary epithelial cells. Science 1994; 263: 526–529
   PubMed Web of Science ®Google Scholar
• Billings P, Habres J. A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor. Proc Natl Acad Sci USA 1991; 89: 3120–3124
   Web of Science ®Google Scholar
• Carew J, Kennedy A. Identification of a proteolylic activity which responds to anticarcinogenic protease inhibitors in C3H/10T1/2 cells. Cancer Lett 1990; 49: 153–163
   PubMed Web of Science ®Google Scholar
• Yavelow J, Caggana M, Beck K. Proteases occurring in the cell membrane: A possible cell receplor for the Bowman-Birk type of protease inhibitors. Cancer Res 1987; 47: 1598–1601
   PubMed Web of Science ®Google Scholar
• Benedict C, Ren L, Clawson G. Nuclear multicatalytic proteinase α subunit RRC3: Differential size, tyrosine phosphorylation, and susceptibility to antisense oligonucleotide treatment. Biochemistry 1995; 34: 9587–9598
   PubMed Web of Science ®Google Scholar
• Cooper E, Stone J. Acute phase reactant proteins in cancer. Adv Cancer Res 1979; 30: 1–44
   PubMedGoogle Scholar
• Takada S, Tsuda M, Mitomi T, et al. Analysis of the tissue and cellular localization of α1-antichymotrypsin by an immunohistochemical technique. Gann 1982; 73: 742–747
   PubMedGoogle Scholar
• Takada S, Tsuda M, Fujinami S, Yamamura M, Mitomi T, Katsunuma J. Incorporation of α1-antichymotrypsin into carcinoma cell nuclei of human stomach adenocarcinoma transplanted into nude mice. Cancer Res 1986; 46: 3688–3691
   PubMed Web of Science ®Google Scholar
• Tsuda M, Masuyama M, Katsunuma T. Inhibition of human DNA polymerase α by α1-anlichymotrypsin. Cancer Res 1986; 46: 6139–6142
   PubMed Web of Science ®Google Scholar
• Tsuda M, Umezawa Y, Masuyama M, Yamaguchi K, Katsunuma T. Effect of α1 -antichymotrypsin on DNA synthesis in perrneabilized human cells. Biochem Biophys Res Commun 1987; 144: 409–414
   PubMed Web of Science ®Google Scholar
• Horisberger M, Tacchini-Vonlanthen M. Ultrastruetural localization of Bowman-Birk inhibitor on thin sections of glycine max (soybean) cv. Maple Arrow by the gold method. Histochemistry 1983; 77: 313–321
   PubMedGoogle Scholar
• Kumatori A, Tanaka K, Inamura N, et al. Abnormally high expression of proteasomes in human leukemic cells. Proc Natl Acad Sci US A 1990; 87: 7071–7075
   PubMed Web of Science ®Google Scholar
• Kanayama H, Tanaka K, Aki M, et al. Changes in expressions of proteasome and ubiquilin genes inhuman renal cancer cells. Cancer Res 1991; 51: 6677–6685
   PubMed Web of Science ®Google Scholar
• Tokes Z, Clawson G. Proteolytic activity associated with the nuclear scaffold: The effect of self-digestion on lamins. J Biol Chem 1989; 264: 15059–15065
   PubMed Web of Science ®Google Scholar
• Seufert W, Fulcher B, Jentsch S. Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature 1995; 373: 78–81
   PubMed Web of Science ®Google Scholar
• Treier M, Slaszewski L, Bohmann D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain. Cell 1994; 78: 787–798
   PubMed Web of Science ®Google Scholar
• Ciechanover A, DiGiuseppe J, Bercovich B, et al. Degradation of nuclear oncoproteins by the ubiquilin system in vitro. Proc Natl Acad Sci USA 1991; 88: 139–143
   PubMed Web of Science ®Google Scholar
• Rogers S, Well R, Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis. Science 1986; 234: 364–369
   PubMed Web of Science ®Google Scholar
• Cavagnaro J, Pierce D, Lucchesi J, Chae C. Association of a protease with polytene chromosomes ofDrosophila melanogaster. J Cell Biol 1980; 87: 415–419
   PubMed Web of Science ®Google Scholar
• Carter D, Efird P, Chae C. Chromatin-bound protease: [3H]Diisopropyl fluorophosphate labeling patterns of chromatin. Biochemistry 1976; 15: 2603–2607
   PubMed Web of Science ®Google Scholar
• Trapani J, Smyth M, Apostolidis V, Dawson M, Browne K. Granule serine proteases are normal nuclear constituents of natural killer cells. J Biol Chem 1994; 269: 18359–18365
   PubMed Web of Science ®Google Scholar